Iulia Diaconu | Immunotherapy Vice President

Iulia Diaconu, Immunotherapy Vice President, ElevateBio

Iulia Diaconu PhD, is Vice President of Immunotherapy & Preclinical development at Elevate Bio and joined the company in April 2019. She is responsible for leading Elevate’s translational immunotherapy programs and developing second generation product candidates. Iulia comes from Bluebird Bio 2014-2019 where she was Associate Director of Immunotherapy and was responsible for preclinical development of immunotherapy CAR/TCR T cell products for various Oncology indications. Iulia was formerly a post-doctoral fellow at Baylor College of Medicine/ Center for Cell and Gene therapy developing CAR T cell and virus specific T cell products for hematological cancers. She started her research career 20 years ago in the pathology department of Oncological Institute, Cluj-Napoca, Romania and she continued her training with a PhD in Pharmacy from University of Medicine and Pharmacy “Iuliu Hatieganu”, Romania studying prognostic and diagnostic markers for endometriosis and ovarian cancer. Iulia also holds a PhD in Medicine from University of Helsinki, Finland, studying efficacy and safety of oncolytic virus therapie


Festival of Biologics Day 2 @ 11:40

Elevate Bio technologies and Immunotherapeutic products

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers